Brian A Willis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Coronary Artery Disease

Top Venues

Clinical pharmacology and therapeutics

CPT: pharmacometrics & systems pharmacology

British journal of clinical pharmacology

University of Minnesota System (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Minnesota System Sep 01 2002 - Jan 31 2007

United States

PHD :: Pharmaceutics

Publications

Oneeb Majid, Youfang Cao, Brian A Willis, Seiichi Hayato, Osamu Takenaka, Bojan Lalovic, Sree Harsha Sreerama Reddy, Natasha Penner, Larisa Reyderman, Sanae Yasuda, Ziad Hussein
Population pharmacokinetics and exposure-response analyses of safety (ARIA-E and isolated ARIA-H) of lecanemab in subjects with early Alzheimer's disease. CPT: pharmacometrics & systems pharmacology (2024)
Ivelina Gueorguieva, Brian A Willis, Laiyi Chua, Kay Chow, C Steven Ernest, Sergey Shcherbinin, Paul Ardayfio, Garrett R Mullins, John R Sims
Donanemab population pharmacokinetics, amyloid plaque reduction, and safety in participants with Alzheimer's disease. Clinical pharmacology and therapeutics (2023)
Ivelina Gueorguieva, Brian A Willis, Laiyi Chua, Kay Chow, C Steven Ernest, Sergey Shcherbinin, Paul Ardayfio, Garrett R Mullins, John R Sims
Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease. Clinical pharmacology and therapeutics (2023)
Mahmoud Al-Kofahi, Mariam A Ahmed, Mutaz M Jaber, Thang N Tran, Brian A Willis, Cheryl L Zimmerman, Maria T Gonzalez-Bolanos, Richard C Brundage, Kyriakie Sarafoglou
An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia. British journal of clinical pharmacology 87 (3) (2020)